How the product works:
Who it is recommended for:
Studies and clinical evidence:
The PIONEER clinical trial programme demonstrated that oral semaglutide significantly reduces HbA1c levels and body weight compared to placebo and other antidiabetic therapies. These findings support its inclusion in international diabetes treatment guidelines.
The medicine works by enhancing insulin response and reducing postprandial glucose levels.
The tablets are taken once daily on an empty stomach with a small amount of water. Patients should wait at least 30 minutes before eating, drinking or taking other medications. Treatment duration and dosage are determined by a healthcare professional.
Contraindications
Side effects
